2024-08-312025-08-302025-08-30false09195592RISEUP HEALTHCARE LTD2026-04-02falseiso4217:GBPxbrli:pure091955922024-08-30091955922025-08-30091955922024-08-312025-08-30091955922023-08-31091955922024-08-30091955922023-09-012024-08-3009195592bus:SmallEntities2024-08-312025-08-3009195592bus:AuditExempt-NoAccountantsReport2024-08-312025-08-3009195592bus:FullAccounts2024-08-312025-08-3009195592bus:PrivateLimitedCompanyLtd2024-08-312025-08-3009195592core:WithinOneYear2025-08-3009195592core:AfterOneYear2025-08-3009195592core:WithinOneYear2024-08-3009195592core:AfterOneYear2024-08-3009195592core:ShareCapital2025-08-3009195592core:SharePremium2025-08-3009195592core:RevaluationReserve2025-08-3009195592core:OtherReservesSubtotal2025-08-3009195592core:RetainedEarningsAccumulatedLosses2025-08-3009195592core:ShareCapital2024-08-3009195592core:SharePremium2024-08-3009195592core:RevaluationReserve2024-08-3009195592core:OtherReservesSubtotal2024-08-3009195592core:RetainedEarningsAccumulatedLosses2024-08-3009195592core:LandBuildings2025-08-3009195592core:PlantMachinery2025-08-3009195592core:Vehicles2025-08-3009195592core:FurnitureFittings2025-08-3009195592core:OfficeEquipment2025-08-3009195592core:NetGoodwill2025-08-3009195592core:IntangibleAssetsOtherThanGoodwill2025-08-3009195592core:ListedExchangeTraded2025-08-3009195592core:UnlistedNon-exchangeTraded2025-08-3009195592core:LandBuildings2024-08-3009195592core:PlantMachinery2024-08-3009195592core:Vehicles2024-08-3009195592core:FurnitureFittings2024-08-3009195592core:OfficeEquipment2024-08-3009195592core:NetGoodwill2024-08-3009195592core:IntangibleAssetsOtherThanGoodwill2024-08-3009195592core:ListedExchangeTraded2024-08-3009195592core:UnlistedNon-exchangeTraded2024-08-3009195592core:LandBuildings2024-08-312025-08-3009195592core:PlantMachinery2024-08-312025-08-3009195592core:Vehicles2024-08-312025-08-3009195592core:FurnitureFittings2024-08-312025-08-3009195592core:OfficeEquipment2024-08-312025-08-3009195592core:NetGoodwill2024-08-312025-08-3009195592core:IntangibleAssetsOtherThanGoodwill2024-08-312025-08-3009195592core:ListedExchangeTraded2024-08-312025-08-3009195592core:UnlistedNon-exchangeTraded2024-08-312025-08-3009195592core:MoreThanFiveYears2024-08-312025-08-3009195592core:Non-currentFinancialInstruments2025-08-3009195592core:Non-currentFinancialInstruments2024-08-3009195592dpl:CostSales2024-08-312025-08-3009195592dpl:DistributionCosts2024-08-312025-08-3009195592core:LandBuildings2024-08-312025-08-3009195592core:PlantMachinery2024-08-312025-08-3009195592core:Vehicles2024-08-312025-08-3009195592core:FurnitureFittings2024-08-312025-08-3009195592core:OfficeEquipment2024-08-312025-08-3009195592dpl:AdministrativeExpenses2024-08-312025-08-3009195592core:NetGoodwill2024-08-312025-08-3009195592core:IntangibleAssetsOtherThanGoodwill2024-08-312025-08-3009195592dpl:GroupUndertakings2024-08-312025-08-3009195592dpl:ParticipatingInterests2024-08-312025-08-3009195592dpl:GroupUndertakingscore:ListedExchangeTraded2024-08-312025-08-3009195592core:ListedExchangeTraded2024-08-312025-08-3009195592dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-08-312025-08-3009195592core:UnlistedNon-exchangeTraded2024-08-312025-08-3009195592dpl:CostSales2023-09-012024-08-3009195592dpl:DistributionCosts2023-09-012024-08-3009195592core:LandBuildings2023-09-012024-08-3009195592core:PlantMachinery2023-09-012024-08-3009195592core:Vehicles2023-09-012024-08-3009195592core:FurnitureFittings2023-09-012024-08-3009195592core:OfficeEquipment2023-09-012024-08-3009195592dpl:AdministrativeExpenses2023-09-012024-08-3009195592core:NetGoodwill2023-09-012024-08-3009195592core:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3009195592dpl:GroupUndertakings2023-09-012024-08-3009195592dpl:ParticipatingInterests2023-09-012024-08-3009195592dpl:GroupUndertakingscore:ListedExchangeTraded2023-09-012024-08-3009195592core:ListedExchangeTraded2023-09-012024-08-3009195592dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-09-012024-08-3009195592core:UnlistedNon-exchangeTraded2023-09-012024-08-3009195592core:NetGoodwill2025-08-3009195592core:IntangibleAssetsOtherThanGoodwill2025-08-3009195592core:LandBuildings2025-08-3009195592core:PlantMachinery2025-08-3009195592core:Vehicles2025-08-3009195592core:FurnitureFittings2025-08-3009195592core:OfficeEquipment2025-08-3009195592core:AfterOneYear2025-08-3009195592core:WithinOneYear2025-08-3009195592core:ListedExchangeTraded2025-08-3009195592core:UnlistedNon-exchangeTraded2025-08-3009195592core:ShareCapital2025-08-3009195592core:SharePremium2025-08-3009195592core:RevaluationReserve2025-08-3009195592core:OtherReservesSubtotal2025-08-3009195592core:RetainedEarningsAccumulatedLosses2025-08-3009195592core:NetGoodwill2024-08-3009195592core:IntangibleAssetsOtherThanGoodwill2024-08-3009195592core:LandBuildings2024-08-3009195592core:PlantMachinery2024-08-3009195592core:Vehicles2024-08-3009195592core:FurnitureFittings2024-08-3009195592core:OfficeEquipment2024-08-3009195592core:AfterOneYear2024-08-3009195592core:WithinOneYear2024-08-3009195592core:ListedExchangeTraded2024-08-3009195592core:UnlistedNon-exchangeTraded2024-08-3009195592core:ShareCapital2024-08-3009195592core:SharePremium2024-08-3009195592core:RevaluationReserve2024-08-3009195592core:OtherReservesSubtotal2024-08-3009195592core:RetainedEarningsAccumulatedLosses2024-08-3009195592core:NetGoodwill2023-08-3109195592core:IntangibleAssetsOtherThanGoodwill2023-08-3109195592core:LandBuildings2023-08-3109195592core:PlantMachinery2023-08-3109195592core:Vehicles2023-08-3109195592core:FurnitureFittings2023-08-3109195592core:OfficeEquipment2023-08-3109195592core:AfterOneYear2023-08-3109195592core:WithinOneYear2023-08-3109195592core:ListedExchangeTraded2023-08-3109195592core:UnlistedNon-exchangeTraded2023-08-3109195592core:ShareCapital2023-08-3109195592core:SharePremium2023-08-3109195592core:RevaluationReserve2023-08-3109195592core:OtherReservesSubtotal2023-08-3109195592core:RetainedEarningsAccumulatedLosses2023-08-3109195592core:AfterOneYear2024-08-312025-08-3009195592core:WithinOneYear2024-08-312025-08-3009195592core:Non-currentFinancialInstrumentscore:CostValuation2024-08-312025-08-3009195592core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-08-312025-08-3009195592core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-08-312025-08-3009195592core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-08-312025-08-3009195592core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-08-312025-08-3009195592core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-08-312025-08-3009195592core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-08-312025-08-3009195592core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-08-312025-08-3009195592core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-08-312025-08-3009195592core:Non-currentFinancialInstrumentscore:CostValuation2025-08-3009195592core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-08-3009195592core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-08-3009195592core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-08-3009195592core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-08-3009195592core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-08-3009195592core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-08-3009195592core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-08-3009195592core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-08-3009195592core:Non-currentFinancialInstrumentscore:CostValuation2024-08-3009195592core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-08-3009195592core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-08-3009195592core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-08-3009195592core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-08-3009195592core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-08-3009195592core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-08-3009195592core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-08-3009195592core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-08-3009195592bus:Director12024-08-312025-08-3009195592core:FurnitureFittingsToolsEquipment2024-08-3009195592core:FurnitureFittingsToolsEquipment2025-08-3009195592core:FurnitureFittingsToolsEquipment2024-08-312025-08-30

RISEUP HEALTHCARE LTD

Registered Number
09195592
(England and Wales)

Unaudited Financial Statements for the Year ended
30 August 2025

RISEUP HEALTHCARE LTD
Company Information
for the year from 31 August 2024 to 30 August 2025

Director

BHANDARI, Poonam

Registered Address

Dorley House
Norwich Road
Besthorpe
NR17 2LB

Registered Number

09195592 (England and Wales)
RISEUP HEALTHCARE LTD
Statement of Financial Position
30 August 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets31,6256,352
1,6256,352
Current assets
Debtors41,296,064909,210
Cash at bank and on hand436,665499,404
1,732,7291,408,614
Creditors amounts falling due within one year5(180,422)(167,309)
Net current assets (liabilities)1,552,3071,241,305
Total assets less current liabilities1,553,9321,247,657
Net assets1,553,9321,247,657
Capital and reserves
Called up share capital100100
Other reserves5,0005,000
Profit and loss account1,548,8321,242,557
Shareholders' funds1,553,9321,247,657
The financial statements were approved and authorised for issue by the Director on 2 April 2026, and are signed on its behalf by:
BHANDARI, Poonam
Director
Registered Company No. 09195592
RISEUP HEALTHCARE LTD
Notes to the Financial Statements
for the year ended 30 August 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
Government grants or assistance
Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received. A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.
2.Average number of employees

20252024
Average number of employees during the year4540
3.Tangible fixed assets

Vehicles

Fixtures & fittings

Office Equipment

Total

££££
Cost or valuation
At 31 August 2422,7892472,99326,029
At 30 August 2522,7892472,99326,029
Depreciation and impairment
At 31 August 2419,1424848719,677
Charge for year3,647829984,727
At 30 August 2522,7891301,48524,404
Net book value
At 30 August 25-1171,5081,625
At 30 August 243,6471992,5066,352
4.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables656,890404,390
Other debtors639,174504,820
Total1,296,064909,210
5.Creditors: amounts due within one year

2025

2024

££
Taxation and social security134,617129,958
Other creditors44,92137,243
Accrued liabilities and deferred income884108
Total180,422167,309
6.Related party transactions
At the period end, included in other debtors, is a balance of £635,000 (2023: £480,000) due from Riseup Properties Limited, a company in which Poonam Bhandari is a director. During the period, interest of £Nil was received on this balance. At the period end, included in other creditors, is a balance of £3,199 (2023: £3,199) due to Poonam Bhandari who is a director of Riseup Properties Limited.